TCIM
IRMD icon

TIAA CREF Investment Management’s iRadimed IRMD Stock Holding History

TIAA CREF Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,277
Closed -$251K – 3012
2018
Q4 		$251K Buy
+10,277
New +$276K ﹤0.01% 2823
2017
Q2 		– Sell
-13,049
Closed -$116K – 3155
2017
Q1 		$116K Sell
13,049
-217
-2% -$2.01K ﹤0.01% 3034
2016
Q4 		$147K Sell
13,266
-2,086
-14% -$22.5K ﹤0.01% 3061
2016
Q3 		$261 Buy
15,352
+1,868
+14% +$34.6K ﹤0.01% 3018
2016
Q2 		$293K Buy
13,484
+3,963
+42% +$71.3K ﹤0.01% 3041
2016
Q1 		$182K Sell
9,521
-5,260
-36% -$101K ﹤0.01% 2994
2015
Q4 		$414K Buy
14,781
+5,260
+55% +$149K ﹤0.01% 2948
2015
Q3 		$232K Hold
9,521
– – ﹤0.01% 3022
2015
Q2 		$222K Buy
+9,521
New +$174K ﹤0.01% 3107

Other funds holding IRMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TIAA CREF Investment Management's IRMD Position: Q1 2019 in Review

TIAA CREF Investment Management sold out of iRadimed (IRMD) in Q1 2019, closing a stake of 10,277 shares — an estimated $251K sold.

TIAA CREF Investment Management first reported a position in IRMD in Q2 2015 and held it in 9 quarters. The position peaked at $414K in Q4 2015. 64 funds tracked by Wall St. Rank hold IRMD as of Q1 2019.

  • TIAA CREF Investment Management reported no remaining iRadimed position as of Q1 2019 after selling out during the quarter.
  • TIAA CREF Investment Management sold 10,277 iRadimed shares in Q1 2019, an estimated $251K.
  • TIAA CREF Investment Management first reported a position in iRadimed in Q2 2015 and held it in 9 quarters.
  • TIAA CREF Investment Management's iRadimed position peaked at $414K in Q4 2015.
  • 64 funds tracked by Wall St. Rank held iRadimed as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.